ResVita Bio is a synthetic biology startup developing treatments for skin diseases. Leveraging the unique capabilities of topical genetically engineered bacteria, our platform is designed to produce and deliver therapeutic proteins directly to affected areas, offering a dynamic and sustained approach to treatment. This method circumvents the challenges associated with traditional protein therapies, such as stability and short half-lives, by establishing a living system that can continuously synthesize and secrete therapeutic agents. ResVita Bio's cutting-edge platform promises to transform treatments for a range of conditions, beginning with the rare skin disease Netherton Syndrome and Severe Atopic Dermatitis.
Our technology at ResVita Bio revolutionizes skin health by targeting the underlying protein imbalances that contribute to aging and disease. Traditionally, small molecules have been used to mimic missing proteins in treating skin conditions, but they often lack precision and can have toxic effects due to their long half-lives and systemic absorption. Gene therapy holds great promise in delivering the necessary proteins, but viral vectors used in traditional gene therapy approaches can pose serious toxicity concerns and lack adjustability.
ResVita Bio takes a different approach by utilizing our proprietary cells, which are applied topically in a moisturizer. These cells have been extensively dermatologically tested and proven to be non-irritating and non-allergenic. Importantly, our cells can be easily washed off at any point, ensuring safety and flexibility. By applying our cells topically, they continuously produce the missing proteins directly in the skin, restoring the delicate protein balances essential for skin health. This precise and adjustable delivery system offers a transformative solution for various skin diseases and conditions.
Chief Executive Officer
Co-Founder & Board Member
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.